文献速递间质性肺疾病

高强度间歇训练在间质性肺疾病中的随机对照试验

High intensity interval training in interstitial lung disease: a randomized controlled trial.
PubMed 文献 · Am J Respir Crit Care Med · 2026-09-10

本研究将131例纤维化间质性肺疾病患者随机分配至高强度间歇训练(HIIT)或中等强度持续训练(MICT),进行为期8周、每周两次的肺康复。结果显示两组在周期耐力时间、6分钟步行距离及所有次要结局上均无显著组间差异,HIIT安全且耐受良好,可作为MICT的替代方案。

要点

  • HIIT与MICT在改善fILD患者运动耐力方面无显著差异。
  • HIIT在fILD患者中安全且耐受良好,无不良事件。
  • HIIT可作为fILD患者肺康复中MICT的替代训练方式。

核心结论

  • 在纤维化间质性肺疾病患者中,HIIT在改善运动耐力方面未优于MICT。
  • HIIT安全且耐受良好,可作为MICT的替代方案。

研究设计与样本

  • 随机对照试验,131例纤维化间质性肺疾病患者按运动性低氧血症分层后随机分配至HIIT或MICT。
  • 干预为标准8周、每周两次的肺康复计划,采用线性混合模型和意向性分析比较组间差异。

主要发现

  • 两组肺康复后周期耐力时间均出现临床重要改善,组间无差异(MD -63秒,95%CI -195至68秒)。
  • 6分钟步行距离组间无差异(MD 4米,95%CI -20至28米),所有次要结局亦无组间差异。
  • 两组均无不良事件,完成肺康复、达到规定强度、时长和进阶的比例相似。

关键数值与推荐

  • 周期耐力时间组间平均差异为-63秒(95%CI -195至68秒),对象为完成8周肺康复的fILD患者。
  • 6分钟步行距离组间平均差异为4米(95%CI -20至28米),对象为完成8周肺康复的fILD患者。

临床怎么用

  • 对于纤维化间质性肺疾病患者,肺康复中可选择HIIT作为MICT的替代训练方式。
  • HIIT在fILD患者中安全且耐受良好,可考虑纳入肺康复方案。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RATIONALE: Pulmonary rehabilitation (PR) is an effective guideline-recommended intervention for people with interstitial lung disease (ILD). However, not all participants experience clinically meaningful improvements. The current PR approach may not represent the optimal form of exercise training for people with ILD. OBJECTIVES: To compare the effects of high intensity interval training (HIIT) with the standard PR method of moderate intensity continuous training (MICT) in fibrotic ILD (fILD). METHODS: 131 participants with fILD were randomized, stratified for exertional desaturation (SpO2 < or ≥ 90%), to undertake HIIT or MICT during a standard 8-week, twice-weekly PR program. Cycle endurance time (primary outcome), 6-minute walk distance (6MWD), symptoms, health-related quality of life, skeletal muscle changes, and physical activity levels assessed at baseline, immediately after PR, and 6-months were compared between groups using linear mixed models and intention-to-treat analysis. MEASUREMENTS AND MAIN RESULTS: Clinically important improvements in cycle endurance time were evident following PR for HIIT and MICT with no between-group difference (MD -63s, 95%CI -195 to 68s). A similar response was seen for 6MWD (MD 4m, 95%C1 -20 to 28m) and all secondary outcomes with no difference between HIIT and MICT. There were no adverse events in either group. A similar proportion of participants in each group completed PR, achieved the prescribed intensity, duration and progression. CONCLUSION: HIIT did not result in greater improvements in exercise endurance than MICT in people with fILD. HIIT was safe and well-tolerated, and may serve as an alternative to MICT in people with fILD.

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

引用

  1. Dowman L, May AK, Hill CJ, et al. High intensity interval training in interstitial lung disease: a randomized controlled trial. Am J Respir Crit Care Med. 2026. PMID: 42720586. doi:10.1093/ajrccm/aamag446

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。